July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with Siemens Healthineers to support the company’s Phase 2 clinical trial of the MagSense imaging agent in patients with HER2+ breast cancer.

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection by the U.S. Food and Drug Administration (FDA), with zero Form 483 observations.

The FDA inspection reviewed QT Imaging’s Quality Management System (QMS) and related processes that support the company’s operations, with no Form 483 observations issued. The inspector also provided positive feedback regarding the organization of QT Imaging’s QMS and the company’s responsiveness throughout the inspection process.

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which automatically identifies suspected lesions on breast MRI.

QP-Breast assists radiologists during the interpretation of breast MRI studies by providing accurate detection of lesions suspicious for breast cancer and generating clear, user-friendly reports that slot into existing hospital systems.

June 29, 2026 – GE HealthCare has introduced Allia platform upgrade pathways designed to help customers modernize select Innova, Discovery and Allia Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime and minimize disruption to clinical operations.

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age, IVF assisted pregnancies, rising obesity rates and higher prevalence of hypertension and diabetes, means that more cases require specialist monitoring, advanced imaging, and multidisciplinary care. At the same time, clinical teams are stretched and facing increasing administrative demands. 

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy capabilities for the Mammomat B.brilliant mammography system from Siemens Healthineers.

Freeland Systems

People in healthcare technology love to talk about digital transformation like it just started happening. Cloud, artificial intelligence (AI), mobile: the narrative is that we are finally dragging medicine into the modern era. But if you were in a cardiac ultrasound lab in the 1980s, you know the real story started a lot earlier, and it started with people who were simply fed up with how hard it was to do the job well.

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four additional hospitals within the UHS Nevada Health System. The implementation expands Radin presence to eight hospitals across Nevada.

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to First Read1, AI designed to analyze chest radiographs and generate preliminary high-quality radiology report text for that analysis.

June 25, 2026 — Radiologists performing no interventional radiology-related (IR-related) work increased from one-third in 2008 to one-half in 2023. Among radiologists with IR-related work, the proportion whose work was a majority IR-related increased from 12.6% in 2008 to 18.5% in 2023.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now